Answers are grounded in this paper and cite their sources.
Clostridium perfringens epsilon toxin (ETX), produced by type B and D strains, is a highly potent pore-forming toxin that causes rapid hemolysis of human erythrocytes. Previous studies implicated P2X7/P2Y13 purinergic receptors and MAL protein in this selectivity, but downstream events remain unclear. We used an exploratory, hypothesis-generating design combining LC-MS/NMR metabolomics with amino acid, antioxidant, and pharmacological interventions. ETX treatment was accompanied by widespread decreases in metabolite abundance, with alanine, aspartate and glutamate metabolism being the most affected annotated pathway. L-Methionine, L-histidine, L-cysteine, L-lysine, and high concentrations of L-aspartate reduced ETX-induced hemolysis to varying extents. N-Acetyl-L-cysteine (NAC) reduced hemolysis, whereas the NADPH oxidase inhibitor diphenyleneiodonium (DPI) did not. Inhibitors associated with PI3K/Akt (perifosine, API-2), MEK/ERK (BIX02189, TCS ERK 11e), and Ras/Raf (Kobe0065, Antineoplaston A10, LY3009120) also reduced hemolysis. These observations are consistent with redox-associated and Ras-related processes, but they do not demonstrate activation of these pathways: Ras-GTP, Akt/ERK phosphorylation, kinase activity, ROS, and glutathione status were not measured, and immunoblotting for phospho-Akt/ERK was inconclusive. Protective effects generally required high, often supraphysiological concentrations, and nonspecific physicochemical effects cannot be excluded. The study therefore provides preliminary, hypothesis-generating evidence and defines the direct biochemical experiments required to test the proposed model.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: